Join us in building the next era of healthcare
Omply is a new global standard for remote care, designed to scale across the world.
A billion euro problem
Doctor shortages, long distances, or simply not being able to get an appointment when it is actually needed are all part of a healthcare crisis that calls for a fundamentally new kind of solution.
Platform first
Omply is the first platform that combines an intuitive mobile application with smart diagnostic devices that transform a smartphone into a doctor’s office.
Ready to scale
This unique combination is ready to take healthcare into a new era within a multibillion dollar market.
Telehealth is growing rapidly
Remote care is becoming the new normal, as the world is changing faster than healthcare systems can adapt. People expect care that is seamless, accessible, and part of everyday life without travel, waiting rooms, or long queues. Until now, technology has mostly offered video connections, but that is no longer enough.
Healthcare demand continues to rise, populations are aging, and resources are increasingly constrained. Remote solutions are no longer just an alternative. They are a critical way to preserve accessible, equitable, and functional care for everyone.
Download our Pitch Deck here:
1 211 B
USD
Telehealth market 2034
1 mrd €
EXIT-valuation within 5 years
22%
GAGR Growth
“I know that beyond games, you also want to make a real impact on the world. This might even be a better investment than Supercell.”
– Pekka Pouta
Doctor in your pocket
No one-size-fits-all exams. Choose the devices that match your needs.
At the core of Omply is a platform that connects patients directly with doctors. With our diagnostic devicises added, physicians can listen to heart and lung sounds, examine ears and skin, and measure temperature, pulse, and oxygen saturation.
Omply’s technology is clinically validated and developed together with doctors. The system is ready to scale across different environments, from homes to workplaces and care facilities.
Omply is built on eEva remote examination technology that is already in broad use around the world.
Latest updates
Global scalability
Omply addresses healthcare needs that account for up to 78 percent of all primary care physician visits.
Ear infections, respiratory illnesses, skin symptoms, abdominal pain, allergies, and other acute conditions can be assessed quickly and accurately through Omply’s remote care solution.
In addition, our technology enables ongoing monitoring of chronic conditions such as asthma and heart disease, independent of time and location.
In Finland alone, more than 20 million primary care physician visits take place each year. This creates a substantial business opportunity for Omply’s remote consultation model.
Take the
next step
At Omply, we believe care should be closer to people, and now is the time to make that a reality.
If you would like to learn more about the investment opportunity, the technology, or where we are headed, leave your contact details here or book a meeting to get in touch with us.
How can we help?
Did you have any questions? Here are short answers to the most common questions.
Omply’s mission is to create a global remote diagnostics platform that brings physician services directly into people’s homes through smart medical devices and an open digital marketplace.
Omply is a spin-off from Finnish health technology company 73Health Oy, which has developed and validated the core B2B2C technology. Their solutions are already in use across four continents, generating over 6,000 remote diagnostic consultations every month. Omply leverages this proven technology, existing IPR, and international network to accelerate development and consumer market entry.
The telehealth market is growing at over 20% annually and is already valued in the hundreds of billions of euros. Growth is driven by aging populations, healthcare workforce shortages, cost pressures and consumer demand for accessible and convenient care. Device-assisted diagnostics and home monitoring represent the fastest-growing segments of this market.
Remote diagnostics based on medical devices, ease of use and global scalability. In addition, Omply differs from traditional video appointments by being an open platform rather than a closed part of a single hospital’s internal network. This makes it possible for doctors to see patients outside of their main employment, for example in the evenings or weekends. In the same way as food delivery platforms transformed the restaurant industry by consolidating logistics onto an open platform, Omply does the same for healthcare: it offers an efficient and flexible way to connect patients with physicians, regardless of physical location or employer. The platform model also opens new opportunities for part-time work, specialist clinics, and niche services within remote care.
The goal is a global market, limited only by the regulatory environment, technical infrastructure, and readiness for digital healthcare services, all of which are rapidly developing and expanding. As a result, scalable services like Omply continuously gain access to new markets across multiple continents, and preparations are already underway to expand beyond Europe through a partner network.
Omply has acquired the mobile application, the underlying technology code, and the related rights from 73Health.
Omply has purchased the full intellectual property rights to the technology as well as the complete source code from 73Health, including documentation, user interfaces, server environments, and development tools. As part of the transaction, key individuals who originally developed the technology will join Omply’s team to ensure continuity of expertise.
While 73Health played a central role as the original developer of the technology, Omply will independently manage the maintenance, further development, and production infrastructure of the application going forward. The team will be expanded as the service scales, and the architecture has been designed to support extensibility and modular development. This ensures that Omply has full control over the maintenance and evolution of its technology, independent of the original developer.
es, it is possible, but it would be extremely difficult and time consuming. While there are several closed video consultation platforms on the market, there is still very limited competition in device enabled remote diagnostics.
Omply’s spin off company, 73Health, was among the first to start developing this model for the B2B2C market, and the technology has already been in real world use for several years. As a result, we have developed an exceptional understanding of the practical and technical requirements of the field.
Omply has exclusive access to 73Health’s expertise, network, and technology, and we also have protections in progress in relation to patent filings. This foundation makes it difficult for others to catch up. We have a multi year head start and a development path that cannot be quickly replicated.